GOSSAMER BIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-120.1M | $105.2M |
| FY2019 | $28.5M | $352.5M | $135.0M |
| FY2020 | $28.7M | $320.7M | $486.1M |
| FY2021 | $29.1M | $121.5M | $183.4M |
| FY2022 | $12.0M | $12.1M | $112.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-120.1M | $105.2M |
| FY2019 | $28.5M | $352.5M | $135.0M |
| FY2020 | $28.7M | $320.7M | $486.1M |
| FY2021 | $29.1M | $121.5M | $183.4M |
| FY2022 | $12.0M | $12.1M | $112.0M |